Authors
Loading...
Narrative review reveals mechanisms of androgen receptor activation in hormone-refractory prostate cancer, highlighting targets for novel receptor-directed therapies.
Dehm et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: